Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Julphar
Cantor Fitzgerald
US Department of Justice
Moodys
Covington
Johnson and Johnson
UBS
Deloitte

Generated: June 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 085732

« Back to Dashboard

NDA 085732 describes PROPOXYPHENE HYDROCHLORIDE W/ ASPIRIN AND CAFFEINE, which is a drug marketed by Watson Labs and is included in one NDA. Additional details are available on the PROPOXYPHENE HYDROCHLORIDE W/ ASPIRIN AND CAFFEINE profile page.

The generic ingredient in PROPOXYPHENE HYDROCHLORIDE W/ ASPIRIN AND CAFFEINE is aspirin; caffeine; propoxyphene hydrochloride. There are twenty-one drug master file entries for this compound. Additional details are available on the aspirin; caffeine; propoxyphene hydrochloride profile page.
Summary for 085732

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength389MG;32.4MG;65MG
Approval Date:Sep 3, 1984TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
McKinsey
Queensland Health
Express Scripts
Fuji
Moodys
Merck
Healthtrust
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.